Komori
Nihon Nohyaku (4997) · InitiativeRestated

Remediation of GMP Deficiencies and Prevention of Recurrence

First written in FY2016. 5 of 7 entries say "Restated". Latest entry: FY2018.

7entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY2017-Q3RestatedFY2018-Q1 – FY20182016: 12017: 420172018: 22018
Same theme, other companies
Resuming manufacturing and shipments and preventing recurrence following GMP deficienciesA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2018RestatedAnnual report

    「The GMP management deficiencies have been fully remediated and manufacturing and shipments have resumed, but the Group will continue working to prevent recurrence.」

    The company reconfirmed the completion of remediation of the GMP deficiencies, the resumption of manufacturing and shipments, and its policy of continuing efforts to prevent recurrence.
  2. FY2018-Q3RestatedAnnual report

    「The GMP management deficiencies have been fully remediated and manufacturing and shipments have resumed, but the Group will continue working to prevent recurrence.」

    The company reconfirmed the completion of remediation of the GMP deficiencies, the resumption of manufacturing and shipments, and its policy of continuing efforts to prevent recurrence.
  3. FY2017RestatedAnnual report

    「The GMP management deficiencies have been fully remediated, and manufacturing and shipments have resumed.」

    The company reconfirmed that the GMP management deficiencies had been fully remediated and that manufacturing and shipments had resumed.
  4. FY2018-Q1RestatedAnnual report

    「The GMP management deficiencies have been fully remediated, and manufacturing and shipments have resumed.」

    The company reconfirmed that the GMP management deficiencies had been fully remediated and that manufacturing and shipments had resumed.
  5. FY2017-Q4AchievedAnnual report

    「The GMP management deficiencies have been fully remediated, and manufacturing and shipments have resumed.」

    The company explicitly stated that the GMP management deficiencies had been fully remediated and that manufacturing and shipments had resumed. However, discussions continue with some supply partners regarding responsibility for the costs of the voluntary recall.
  6. FY2017-Q3RestatedAnnual report

    「The GMP management deficiencies have been remediated, and manufacturing and shipments have resumed.」

    The company reconfirmed the remediation of the GMP deficiencies and the resumption of manufacturing and shipments.
  7. FY2016First statedAnnual report

    「The GMP management deficiencies identified have been remediated, and manufacturing and shipments have resumed. The Group will continue working to prevent recurrence.」

    The company reported remediation of the GMP management deficiencies and the resumption of manufacturing and shipments, and indicated a policy of continuing efforts to prevent recurrence.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Nihon Nohyaku yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.